Search

Displaying results 4261 - 4270 of 5449 in total
  1. Drug

    Droloxifene

    go.drugbank.com/drugs/DB15641
    Experimental

    Droloxifene may have an effect on bone and breast tissue because it induces apoptosis. … It may have a particular role in situations in which rapid pharmacokinetics, or an increased antiestrogenic to estrogenic ratio, are required.

  2. Drug

    Chromic citrate

    go.drugbank.com/drugs/DB14526
    Experimental

  3. Drug

    Mipomersen

    go.drugbank.com/drugs/DB05528
    Approved

    It is marketed under the brand name Kynamro in the United States, and the FDA label includes a black box warning of hepatoxicity.

  4. Drug

    Abemaciclib

    go.drugbank.com/drugs/DB12001
    ApprovedInvestigational

    It is either given alone in patients who has undergone endocrine therapy and chemotherapy after the metastasis of cancer, or in combination with [DB00947].

    Products: VERZENIO 50 MG, VERZENIO® 100 MG
  5. Drug

    BIIB015

    go.drugbank.com/drugs/DB06304
    Investigational

    It has been investigated for the treatment of subjects with relapsed or refractory solid tumours.

  6. Drug

    Erythritol

    go.drugbank.com/drugs/DB04481
    Investigational

    It is twice as sweet as sucrose and can be used as a coronary vasodilator.

  7. Drug

    Corticosterone

    go.drugbank.com/drugs/DB04652
    Investigational

    (From Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1437)

  8. Drug

    Eritoran

    go.drugbank.com/drugs/DB04933
    Investigational

    It is being developed by Eisai Research Institute of Boston for the treatment of severe sepsis.

  9. Drug

    Caprospinol

    go.drugbank.com/drugs/DB05263
    Experimental

    It also improves the brain histopathology and recovers memory function.

  10. Drug

    Prostaglandin G2

    go.drugbank.com/drugs/DB03866
    Experimental

    It is further converted by a series of specific enzymes to the series 2 prostaglandins. [PubChem]